Pharmarise Holdings Cash Flow Statement

Financials in millions JPY. Fiscal year is June - May.

Millions JPY. Fiscal year is Jun - May.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '25 May 31, 2025	May '24 May 31, 2024	May '23 May 31, 2023	May '22 May 31, 2022	May '21 May 31, 2021
Net Income	8	143	1,049	1,322	1,202
Depreciation & Amortization	1,493	1,170	1,224	1,308	1,344
Loss (Gain) From Sale of Assets	256	297	396	216	50
Loss (Gain) From Sale of Investments	-3	-19	-	-	4
Other Operating Activities	-426	-990	-745	-869	-610
Change in Accounts Receivable	392	1,437	482	-1,319	365
Change in Inventory	-1,091	-26	68	286	56
Change in Accounts Payable	910	137	13	-500	-582
Change in Other Net Operating Assets	-228	565	33	269	116
Operating Cash Flow	1,311	2,714	2,520	713	1,945
Operating Cash Flow Growth	-51.70%	7.70%	253.44%	-63.34%	23.73%
Capital Expenditures	-637	-472	-380	-379	-508
Sale of Property, Plant & Equipment	3	16	32	2	41
Cash Acquisitions	-301	-2,401	-180	-	-
Sale (Purchase) of Intangibles	-65	-147	-162	-87	-44
Investment in Securities	49	43	-	-	10
Other Investing Activities	-3,510	-47	-13	171	-569
Investing Cash Flow	-4,462	-3,120	-703	-292	-1,076
Long-Term Debt Issued	5,100	6,100	1,700	2,000	2,500
Short-Term Debt Repaid	-	-	-	-	-20
Long-Term Debt Repaid	-3,716	-2,586	-2,419	-2,636	-2,857
Total Debt Repaid	-3,716	-2,586	-2,419	-2,636	-2,877
Net Debt Issued (Repaid)	1,384	3,514	-719	-636	-377
Repurchase of Common Stock	-	-340	-	-2	-36
Common Dividends Paid	-224	-127	-131	-131	-129
Other Financing Activities	-221	-276	-222	-265	-186
Financing Cash Flow	939	2,771	-1,072	-1,034	-728
Miscellaneous Cash Flow Adjustments	3	1	-2	-	-1
Net Cash Flow	-2,209	2,366	743	-613	140
Free Cash Flow	674	2,242	2,140	334	1,437
Free Cash Flow Growth	-69.94%	4.77%	540.72%	-76.76%	17.50%
Free Cash Flow Margin	1.06%	4.12%	4.11%	0.65%	2.75%
Free Cash Flow Per Share	59.53	213.04	171.61	26.94	116.15
Cash Interest Paid	191	71	55	66	75
Cash Income Tax Paid	436	726	836	870	609
Levered Free Cash Flow	457.13	2,824	1,975	221	1,420
Unlevered Free Cash Flow	568.38	2,866	2,009	261.63	1,466
Change in Working Capital	-17	2,113	596	-1,264	-45

Source: S&P Global Market Intelligence. Standard template. Financial Sources.